P252 Results of a phase 2/3 study of SCIG 20% in PIDD patients in North America

Autor: Suez, D., Melamed, I., Hussain, I., Stein, M., Gupta, S., Paris, K., Bourgeois, C., Leibl, H., McCoy, B., Yel, L.
Zdroj: In Annals of Allergy, Asthma & Immunology November 2016 117(5) Supplement:S97-S97
Databáze: ScienceDirect